The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells

Blood

Volumn 100, Issue 6, 2002, Pages 2063-2070

  Challier, Cécile ^a,b,c,d   Cocault, Laurence ^a,b,c,d   Berthier, Rolande ^a,b,c,d   Binart, Nadine ^a,b,c,d   Dusanter Fourt, Isabelle ^a,b,c,d   Uzan, Georges ^a,b,c,d   Souyri, Michèle ^a,b,c,d  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSERM   (France)

^c Hôpital Cochin ^*  (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PROLACTIN RECEPTOR; PROTEIN MPL; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; EMBRYO CELL; FETUS LIVER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0037105611     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.6.2063.h81802002063_2063_2070     Document Type: Article

References (55)

1. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis
2. Thrombopoietin: The primary regulator of platelet production
3. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand
4. Thrombopoietin (c-mp1 ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro
5. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice
6. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy
7. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors
8. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice
9. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice
10. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates
11. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice
12. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells
13. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells
14. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1 + cells into rapid division
15. Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
16. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl
17. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mp1-deficient mice
18. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin
19. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors
20. Role of c-mp1 in early hematopoiesis
21. The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells
22. The prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitors
23. Versatile retroviral vectors for potential use in gene therapy
24. Intracellular pathways activated by erythropoietin
25. Rapid and efficient site-specific mutagenesis without phenotypic selection
26. Ectopic expression of murine TPO receptor (c-mp1) in mice is pathogenic and induces erythroblastic proliferation
27. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells
28. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20
29. Electroporation in 'intracellular' buffer increases cell survival
30. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors
31. Production of high-titer helper-free retroviruses by transient transfection
32. A new feature of Mpl receptor: Ligand-induced transforming activity in FRE rat fibroblasts
33. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse
34. -/- erythroid progenitors and replaces EpoR in a synergistic interaction with c-kit
35. + progenitors
36. Thrombopoietin, but not erythropoietin, promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro
37. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: Distinct interactions with the ligands for c-kit and FLT3
38. +
39. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood
40. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
41. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
42. Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo
43. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
44. Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells
45. The in vitro development of blastocystderived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium
46. Multiple hematopoietic line-ages develop from embryonic stem (ES) cells in culture
47. Hematopoietic development of embryonic stem cells in vitro: Cytokine and receptor gene expression
48. Hematopoietic commitment during embryonic stem cell differentiation in culture
49. Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells
50. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation
51. Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro
52. The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis
53. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA
54. -/- mouse embryonic stem cells
55. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro